The Effectiveness and Safety of Moxibustion for Treating Knee Osteoarthritis: A PRISMA Compliant Systematic Review and Meta-Analysis of Randomized Controlled Trials
Table 4
Subgroup analysis of the total effective rate for each variable.
Variable
No. of trials
No. of participants
RR (95% CI)
value
I2 value
Events
Total
Quality
High quality
6
367
433
1.23 [1.13, 1.33]
0.60
0%
Low quality
21
1464
1740
1.20 [1.15, 1.25]
Western medicine
Celecoxib
2
174
194
1.15 [1.04, 1.27]
0.08
52.4%
Glucosamine sulfate
3
210
241
1.22 [1.10, 1.34]
Sodium hyaluronate
5
302
358
1.09 [1.00, 1.19]
Ibuprofen
7
474
558
1.20 [1.11, 1.29]
Diclofenac sodium
8
521
654
1.29 [1.19, 1.40]
Period
Two weeks
4
203
260
1.31 [1.14, 1.49]
0.31
16.9%
Three weeks
7
458
563
1.23 [1.13, 1.33]
Four weeks
9
626
740
1.19 [1.12, 1.27]
Eight weeks
3
205
226
1.13 [1.04, 1.23]
value and I2 value test for heterogeneity between subgroups.
